Skip to content
OpenCapital
Get started

Maravai LifeSciences Holdings, Inc. MRVI TriLink — Adjusted EBITDA for reportable segments

Similar metrics at other companies

Clean Harbors logo
CLHTotal Segment Revenues — Total Reportable Segment Adjusted EBITDA
$323.38M+6.8%
Cronos Group logo
CRONReportable Segment — Adjusted EBITDA
$5.08M+122%
MSCI logo
MSCITotal reportable segment operating revenues — Adjusted EBITDA
$491M+19.3%
Open Text logo
OTEXReportable Segment — Adjusted EBITDA
$437.91M+10.8%
WillScot Holdings Corporation logo
WSCReportable Segment — Adjusted EBITDA
$211.01M-7.8%
NCR Atleos logo
NATLT&T — Adjusted EBITDA by segment
$7.75M-11.4%

Other financials

Income statement

See full
Revenue$65.8M+40.5%
Gross profit$33.7M+336%
Operating income-$2.2M+95.6%
Net income-$3.7M+87.5%
EPS (diluted)-$0.02+90.5%

Balance sheet

See full
Cash & equivalents$165.9M-41.8%
Total debt$270.9M-17.1%
Total equity$211.6M-29.6%
Total assets$713.2M-25.7%

Cash flow

See full
Operating cash flow$8.7M+192%
CapEx$4.4M-1.4%
Free cash flow$4.2M+130%

Valuation

See full
Market cap$902.74M+204%
Enterprise value$1.01B+198%
P/S4.4×+3.2×

Profitability

See full
Gross margin29.3%-8.0pp
Operating margin-82.2%-16.6pp
Net margin-51.1%-9.9pp
FCF margin-25.7%—

Returns & leverage

See full
Return on equity-40.8%-4.0pp
Debt / equity1.3×+0.2×
Current ratio5.9×-0.1×

Where this comes from

Reported directly by Maravai LifeSciences Holdings, Inc. in its filing.

Tagged under the XBRL concept mrvi:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization.

The official record: Maravai LifeSciences Holdings, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Maravai LifeSciences Holdings, Inc.'s trilink — adjusted ebitda for reportable segments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Maravai LifeSciences Holdings, Inc.'s trilink — adjusted EBITDA for reportable segments?
Maravai LifeSciences Holdings, Inc. (MRVI) reported trilink — adjusted EBITDA for reportable segments of $17.26M in Q1 2026.
How has Maravai LifeSciences Holdings, Inc.'s trilink — adjusted EBITDA for reportable segments changed year-over-year?
Maravai LifeSciences Holdings, Inc.'s trilink — adjusted EBITDA for reportable segments increased by 293.9% year-over-year, from -$8.9M to $17.26M.
What does trilink — adjusted EBITDA for reportable segments mean?
Measures the operational profitability of the TriLink segment by excluding interest, taxes, depreciation, amortization, and non-recurring charges. This metric serves as a key indicator of the segment's core cash-generating capability and operational efficiency. It allows investors to assess the underlying performance of the nucleic acid production business independent of capital structure or accounting adjustments.